These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5737241)

  • 1. [Modern aspects of arteriosclerosis therapy: influence of HCG and FSH on thrombelastographic behavior].
    Barlattani M; Carignola W; Garbagnati N; Guglielmi G
    Clin Ter; 1968 Aug; 46(4):325-38. PubMed ID: 5737241
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the behavior of tests of hemostasis in arteriosclerotic patients treated with HCG].
    Cajozzo A; Citarrella P; D'Eredità F
    Boll Soc Ital Biol Sper; 1970 Mar; 46(6):315-7. PubMed ID: 5458662
    [No Abstract]   [Full Text] [Related]  

  • 3. The induction of ovulation with FSH and HCG.
    Ansbacher R
    Mil Med; 1973 Mar; 138(3):149-51. PubMed ID: 4631485
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
    Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
    Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of ovarian insufficiency by gonadotrophins.
    Crooke AC; Sutaria UD; Bertrand PV
    Endocrinol Exp; 1973; 7(4):275-82. PubMed ID: 4543645
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormonal replacement therapy with HCG and HU-FSH in thalassaemic patients affected by hypogonadotropic hypogonadism.
    Cisternino M; Manzoni SM; Coslovich E; Autelli M
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():885-90. PubMed ID: 10091162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stimulation of ovaries with animal hypophyseal FSH-active gonadotropin].
    Daume E
    Geburtshilfe Frauenheilkd; 1966 May; 26(5):600-3. PubMed ID: 5935256
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of gonadotropin therapy in hypogonadotropic anovulation].
    Groot-Wassink K; Pfüller B; Vesper B; Friedrich W; Ide K
    Zentralbl Gynakol; 1982; 104(15):936-41. PubMed ID: 6814100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Indications for FSH therapy].
    Groot-Wassink K
    Zentralbl Gynakol; 1967 Mar; 89(9):291-6. PubMed ID: 5585508
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gonadotropin treatment in corpus luteum insufficiency-induced functional sterility].
    Apró G; Farkas I; Sas M
    Zentralbl Gynakol; 1983; 105(11):681-6. PubMed ID: 6410616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of follicle-stimulating hormone and human chorionic gonadotropin on gonadal steroidogenesis in two siblings with a follicle-stimulating hormone beta subunit mutation.
    Lofrano-Porto A; Casulari LA; Nascimento PP; Giacomini L; Naves LA; da Motta LD; Layman LC
    Fertil Steril; 2008 Oct; 90(4):1169-74. PubMed ID: 17961559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seminal anti-Müllerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism.
    Sinisi AA; Esposito D; Maione L; Quinto MC; Visconti D; De Bellis A; Bellastella A; Conzo G; Bellastella G
    Hum Reprod; 2008 May; 23(5):1029-34. PubMed ID: 18343809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin therapy for infertile men with hypogonadotropic hypogonadism.
    Chudnovsky A; Niederberger CS
    J Androl; 2007; 28(5):644-6. PubMed ID: 17522414
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of FSH, HCG and gestagens on compensatory superovulation in rats].
    Weifenbach H
    Acta Endocrinol (Copenh); 1965 Sep; 50(1):7-14. PubMed ID: 5897070
    [No Abstract]   [Full Text] [Related]  

  • 15. Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination.
    Díaz I; Guillén A; Pacheco A; Requena A; Garcia-Velasco JA
    J Reprod Med; 2008 Jan; 53(1):33-9. PubMed ID: 18251359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Choriostimon therapy in impotentia coeundi and impotentia generandi].
    Bohnenstengel G
    Dermatol Wochenschr; 1967 Sep; 153(38):1049-57. PubMed ID: 5589731
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antibody formation in therapy using animal pituitary FSH].
    Groot-Wassink K; Rohde W
    Zentralbl Gynakol; 1971 Feb; 93(9):290-4. PubMed ID: 5168525
    [No Abstract]   [Full Text] [Related]  

  • 18. [Human gonadotropins in the therapy of functional male sterility].
    Abelli G; Falagario M
    Attual Ostet Ginecol; 1966; 12(5):722-33. PubMed ID: 5992495
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical use of recombinant gonadotropins (FSH, LH, hCG)].
    Antoine JM; Loumaye E; Alvarez S; Merviel P; Cornet D; Mandelbaum J; Salat-Baroux J
    Contracept Fertil Sex; 1997 Feb; 25(2):141-6. PubMed ID: 9116774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of multiple follicular growth with CC + pure FSH + HCG and intrauterine insemination with washed semen].
    Nardo F; D'Agosta S; Bonanno AM
    Minerva Ginecol; 1994 May; 46(5):235-41. PubMed ID: 7936372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.